Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yuanyu Liao"'
Autor:
Xin Guan, Ruiqi Liu, Bojun Wang, Ruxin Xiong, Luying Cui, Yuanyu Liao, Yuli Ruan, Lin Fang, Xiaolin Lu, Xuefan Yu, Dan Su, Yue Ma, Tianjiao Dang, Zhuo Chen, Yuanfei Yao, Chao Liu, Yanqiao Zhang
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 6, Pp n/a-n/a (2024)
Abstract Background Although numerous studies have indicated that activated pyroptosis can enhance the efficacy of antitumour therapy in several tumours, the precise mechanism of pyroptosis in colorectal cancer (CRC) remains unclear. Methods Pyroptos
Externí odkaz:
https://doaj.org/article/6beb11d974954c529a23288c5ac51a03
Autor:
Jiani Yang, Yaqian Du, Yuanfei Yao, Yuanyu Liao, Bojun Wang, Xuefan Yu, Kaikun Yuan, Yanqiao Zhang, Fei He, Piaoping Yang
Publikováno v:
Advanced Science, Vol 11, Iss 13, Pp n/a-n/a (2024)
Abstract Although immunogenic cell death (ICD) inducers evidently enhance the effectiveness of immunotherapy, their potential is increasingly restricted by the development of apoptosis resistance in tumor cells, poor immunogenicity, and low T‐cell
Externí odkaz:
https://doaj.org/article/d4dd178f9d4b406683cce072057985c2
Autor:
Xiaolin Lu, Ruiqi Liu, Yuanyu Liao, Luying Cui, Haoxiu Sun, Dongzhi Zhang, Bojun Wang, Lin Fang, Xin Guan, Yuanfei Yao, Chao Liu, Yanqiao Zhang
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-19 (2023)
Abstract Background Multitarget tyrosine kinase inhibitors (mTKIs) such as Regorafenib and Sorafenib have already been approved for the treatment of many solid tumours. However, the efficacy of mTKIs in colorectal cancer (CRC) is limited; the underli
Externí odkaz:
https://doaj.org/article/fc585cfe9d3042ee8515fa2ca2fbe315
Autor:
Yuanyu Liao, Jiaohua Yu, Yuxin Zhan, Yunfang Liu, Yaoling Zhou, Huan Wang, Xinghong Liu, Weiwei Wang, Yu Ma, Fenfen Lan
Publikováno v:
PLoS ONE, Vol 19, Iss 6, p e0306494 (2024)
[This corrects the article DOI: 10.1371/journal.pone.0303858.].
Externí odkaz:
https://doaj.org/article/043a32a3ca664058a4c6945d98e420e1
Autor:
Yuanyu Liao, Jiaohua Yu, Yuxin Zhan, Yunfang Liu, Yaoling Zhou, Huan Wang, Xinghong Liu, Weiwei Wang, Yu Ma, Fenfen Lan
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0303858 (2024)
ObjectiveThe study aims to explore the driving forces behind physical activity engagement among patients with chronic obstructive pulmonary disease, focusing on motivation, opportunity, and capability.DesignA phenomenological qualitative study applie
Externí odkaz:
https://doaj.org/article/3a01694f8e6640dbba7ead9dc8f888c8
Autor:
Haoxiu Sun, Chao Liu, Fang Han, Xiaoyu Lin, Liangyu Cao, Chenxing Liu, Qiuyu Ji, Jinjin Cui, Yuanfei Yao, Bojun Wang, Yuanyu liao, Huan Nie, Yanqiao Zhang, Yu Li
Publikováno v:
Cell Death & Differentiation. 30:922-937
The DNA damage response (DDR) plays crucial roles in cancer prevention and therapy. Poly(ADP-ribose) polymerase 1 (PARP1) mediates multiple signal transduction in the DDR as a master regulator. Uncovering the regulatory factors of PARP1 contributes t
Autor:
Yang Yao, Chao Liu, Bojun Wang, Xin Guan, Lin Fang, Fei Zhan, Haoxiu Sun, Hengzhen Li, Changjie Lou, Feihu Yan, Xiaolin Lu, Luying Cui, Yuanyu Liao, Shuling Han, Yuanfei Yao, Yanqiao Zhang
Publikováno v:
Cancer letters. 533
Homeobox B9 (HOXB9) is involved in the occurrence and development of malignant tumors. However, the functions and underlying molecular mechanisms of HOXB9 in pancreatic cancer have yet to be identified. In this study, we find that both HOXB9 mRNA and
Autor:
Junqing Gan, Xiao-Xue Du, Shumin Li, Xiaodong Ling, Yanjing Li, Yuxian Bai, Yu Meng, Peng Huang, Yuanyu Liao, Lisha Li
Publikováno v:
European journal of pharmacology. 854
Esophageal cancer, especially esophageal squamous cell carcinoma (ESCC) threatens so many lives in China every year. Traditional treatment of ESCC has usually been disappointing. The development of novel therapy is worth investigation. We have previo